Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GPR146: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GPR146 (G protein-coupled receptor 146) is a class A GPCR involved in lipid metabolism, energy homeostasis, and brain function. Genetic variants are associated with altered lipid profiles and metabolic syndrome, with emerging links to Alzheimer's disease through metabolic dysfunction.
No AI portrait yet
| Gene Symbol | GPR146 |
| Full Name | G Protein-Coupled Receptor 146 |
| Chromosome | 7q31.33 |
| Protein Type | Receptor |
| Function | GPR146 signals through G proteins to regulate metabolic pathways: |
| Primary Expression | metabolic tissues and the brain |
| Pathways | MAPK pathway, PI3K |
| UniProt ID | Q96CH4 |
| NCBI Gene ID | 115329 |
| Ensembl ID | ENSG00000173334 |
| GeneCards | GPR146 |
| Human Protein Atlas | GPR146 |
| Gα_s coupling | Activates adenylate cyclase, increasing cAMP levels |
| Gα_i coupling | Inhibits adenylate cyclase in certain cell types |
| β-arrestin signaling | Engages downstream effectors through β-arrestin recruitment |
| Associated Diseases | atherosclerosis, Cardiovascular |
| Interactions | AND, ERK, GENES, LDL, LDLR, LDL RECEPTOR |
| KG Connections | 48 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
GPR146["GPR146"]
SREBP2["SREBP2"]
GPR146 -->|"activates"| SREBP2
ERK["ERK"]
GPR146 -->|"activates"| ERK
cholesterol_metabolism(["cholesterol_metabolism"])
GPR146 -->|"regulates"| cholesterol_metabolism
Atherosclerosis{"Atherosclerosis"}
GPR146 -->|"inhibits"| Atherosclerosis
VLDL["VLDL"]
GPR146 -->|"regulates"| VLDL
LDL_C["LDL-C"]
GPR146 -->|"regulates"| LDL_C
triglycerides["triglycerides"]
GPR146 -->|"regulates"| triglycerides
atherosclerosis{"atherosclerosis"}
GPR146 -->|"activates"| atherosclerosis
LDLR["LDLR"]
GPR146 -->|"inhibits"| LDLR
Cholesterol(["Cholesterol"])
GPR146 -->|"regulates"| Cholesterol
GPR146 -->|"regulates"| SREBP2
Cholesterol_Metabolism(["Cholesterol Metabolism"])
GPR146 -->|"inhibits"| Cholesterol_Metabolism
ERK -->|"regulates"| GPR146
SREBP2 -->|"regulates"| GPR146
GENES["GENES"]
GENES -->|"inhibits"| GPR146
LDLR -->|"inhibits"| GPR146
LDL["LDL"]
LDL -->|"regulates"| GPR146
AND["AND"]
AND -->|"inhibits"| GPR146
style GPR146 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| SREBP2 | activates | protein | 0.72 |
| ERK | activates | protein | 0.72 |
| cholesterol_metabolism | regulates | pathway | 0.72 |
| Cardiovascular | implicated_in | disease | 0.65 |
| Atherosclerosis | inhibits | disease | 0.65 |
| LDL-C | regulates | protein | 0.64 |
| triglycerides | regulates | protein | 0.64 |
| VLDL | regulates | protein | 0.64 |
| atherosclerosis | activates | disease | 0.64 |
| LDL | associated_with | gene | 0.60 |
| oxidative stress response | participates_in | pathway | 0.60 |
| lipid metabolism | participates_in | pathway | 0.60 |
| cardiovascular disease | inhibits | disease | 0.60 |
| LDL | inhibits | gene | 0.60 |
| LDL | activates | gene | 0.60 |
| Cholesterol | regulates | pathway | 0.60 |
| AND | inhibits | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| SURF4 | implicated_in | gene | 0.60 |
| Cholesterol Metabolism | inhibits | pathway | 0.60 |
| ERK | regulates | gene | 0.60 |
| LDLR | inhibits | gene | 0.60 |
| LDLR | associated_with | entity | 0.60 |
| SREBP2 | regulates | gene | 0.60 |
| Cholesterol | implicated_in | pathway | 0.60 |
| Lipid Metabolism | implicated_in | pathway | 0.60 |
| LDL | regulates | gene | 0.60 |
| hypercholesterolemia | activates | disease | 0.56 |
| LDLR | co_expressed_with | gene | 0.50 |
| VLDL | co_expressed_with | protein | 0.50 |
| LDL RECEPTOR | inhibits | protein | 0.50 |
| Cholesterol | inhibits | pathway | 0.50 |
| atherosclerosis | inhibits | disease | 0.50 |
| CHOLESTEROL METABOLISM | inhibits | concept | 0.50 |
| Cholesterol | decreases_risk | pathway | 0.50 |
| atherosclerosis | decreases_risk | disease | 0.50 |
| VLDL | activates | protein | 0.50 |
| Cholesterol | activates | pathway | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GPR146 in their description or question text
No additional research found